Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Thrombosis

• RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
• Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
• Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients
• A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis
• A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants
• ALteplase in Patients With LOW NIHSS and Specified Disabling Deficits
• A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection
• Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
• The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation
• Intra-arterial Thrombolysis After Successful Thrombectomy for Acute Ischemic Stroke in the Posterior Circulation (IAT-TOP)
• Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction
• TIPS Plus Cadonilimab in Advanced HCC With Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study
• H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis
• Study Evaluation of Recombinant Hirudin in Prophylaxis of Post-Operative Deep Vein Thrombosis
• Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus
• Anticoagulation in Post MI LV Thrombus Trial in Nepal
• Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI
• Efficacy of Direct Oral Anticoagulants as a Prophylactic Anticoagulation of Catheter Induced Thrombosis
• DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
• Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
• Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke
• Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
• ProUrokinase in Mild IsChemic strokE (PUMICE)
• Antithrombotic Strategy Based on Clinical Events and 4D-CT for Patients After TAVR
• Endothelial Protection in Post COVID-19 Patients With Sulodexide
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects
• Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
• IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation
• Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
• Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection
• Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer
• Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.
• Endothelial Protection in Convalescent COVID-19 Patients
• Pre- vs. Postoperative Thromboprophylaxis in Pancreatic Surgery
• Apixaban in Patients With Left Ventricular Thrombus
• Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty
• The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19
• The Effectiveness and Safety of 4% Sodium Citrate as a Lock Solution in Central Venous Hemodialysis Catheter
• A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
• A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
• HAIC Combine With Lenvatinib and Camrelizumab for Advanced HCC With PVTT
• Direct Mechanical Thrombectomy Versus Bridging Therapy
• A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091
• Differential EFfects of Dual antIplatelet and Dual aNtithrombotic thErapy on Hemostasis in Chronic Coronary Syndrome Patients
• A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants
• Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures
• Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF
• Thromboprophylaxis in Oesophageal Cancer Patients
• THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)
• Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis
• The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
• Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein
• The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis
• Safety of Anticoagulant Therapy After Variceal Band Ligation
• DOT HeartMate 3 Study
• Rivaroxaban in Left Ventricular Thrombus
• An Exploratory Study of Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants Rivaroxaban in Patients With Left Ventricular Thrombus
• Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis
• Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis
• Ticagrelor in Post-transplant Patients With Pediatric Hepatic Artery Thrombosis (HAT)
• To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects
• Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
• Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
• Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis
• Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19
• Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome
• Comparison of Effectiveness and Complications of Catheter Lock Solutions in Non-tunneled Hemodialysis Catheters
• Continuous Heparin Infusion to Prevent Catheter-related Thrombosis
• Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19
• Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis
• Pre- vs Postoperative Thromboprophylaxis for Liver Resection
• Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)
• Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer
• Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT
• Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting
• Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF
• Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis
• Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET)
• Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial
• COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis
• Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19
• Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）
• HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT
• Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
• Rivaroxaban vs. Warfarin in CVT Treatment
• Reduced Anticoagulation Targets in ECLS (RATE)
• Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion
• COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
• Apixaban for Prevention of Post-angioplasty Thrombosis of Hemodialysis Vascular Access
• Postoperative Thrombosis Prevention in Patients With CD
• The Single, Multiple Dose and Food Effect Study of SHR2285 Tablets on Pharmacokinetics and Pharmacodynamics in Healthy Subjects
• Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy
• Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis
• Prasugrel in Severe COVID-19 Pneumonia
• Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)
• What is the Optimal Antithrombotic Strategy in Patients Presenting With Acute Coronary Syndrome Having Atrial Fibrillation With Indication for Anticoagulants?
• Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis
• Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis
• Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial
• Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation.
• Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19
• Anticoagulation Therapy After Splenectomy in Cirrhosis Patient
• SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
• Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19
• Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19
• Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
• COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial
• Preventing COVID-19 Complications With Low- and High-dose Anticoagulation
• Statins for Venous Event Reduction in Patients With Venous Thromboembolism
• Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
• Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
• A Clinical Study to Test the Efficacy and Safety of CSL312 on Catheter-associated Blood Clot Formation in Subjects With Cancer Who Receive Chemotherapy Through a PICC Line
• The Efficacy and Safety of Batroxobin Combined With Anticoagulation in Cerebral Venous Sinus Thrombosis
• Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
• Prophylactic Anticoagulation for Catheter-related Thrombosis
• The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy Subjects
• Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis
• Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban
• Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism
• Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula
• Diagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein Thrombosis
• Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome
• A Multi-center RCT Trial on Prognosis of Patients With Anticoagulation and DAPT Therapy After LAAC
• Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS
• Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT
• Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis
• A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers
• Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus
• Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study
• Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis
• Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers
• PET Fibrin Imaging of DVT and PE
• Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study
• Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis
• Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants
• Screening for Cancer in Patients With Thromboembolic Disease
• Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi
• Study Investigation Pharmacokinetics and Pharmacodynamics of CS1
• Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study
• Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke
• Resolution of Thrombi in Left Atrial Appendage With Edoxaban
• Dose Effect of Tranexamic Acid on the Incidence of Deep Venous Thrombus in Cardiac Surgery
• Imaging of LAA Thrombosis
• Below Knee DVT Study
• Selective Thromboembolism Prophylaxis After Arthroplasty
• A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation
• Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ)
• The PK/PD Study of SHR2285 Tablets in Healthy Subjects
• Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant
• Efficacy Comparison of Warfarin Versus Rivaroxaban CVT
• Irradiation Stent Placement Plus TACE for HCC and PVTT
• API-CAT STUDY for APIxaban Cancer Associated Thrombosis
• t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection
• The Effect of Rifaximin on Portal Vein Thrombosis
• Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis
• Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality
• Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)
• Calf Deep Vein Thrombosis Treatment Trial
• Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
• Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters.
• Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).
• Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin
• Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines
• PeriOperative ISchemic Evaluation-3 Trial
• Study of Axitinib for Reducing Extent of Venous Tumour Thrombus in Renal Cancer With Venous Invasion
• A Pilot Study on Edoxaban for the Resolution of Left Atrial Thrombosis in Patients With Non-valvular Atrial Fibrillation
• Direct Intra-arterial Thrombectomy in Order to Revascularize AIS Patients With Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals
• Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)
• Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects
• Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis
• Neutrolin Versus Heparin for Locking Hemodialysis Catheters
• TIPS or Anticoagulation in Portal Vein Thrombosis
• Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus
• Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis
• Prevention of Thromboembolic Events in Total Knee Replacement Patients
• Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.
• Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants
• Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma
• Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin
• Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis
• Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement
• Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients
• D-dimer to Guide Anticoagulation Therapy in Patients With Atrial Fibrillation
• Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients
• A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
• Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus
• Subclinical Cardiovascular Disease in Psoriatic Disease
• Tumescent Anesthesia Antibiotic Delivery (TAAD)
• To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants
• The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis
• Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery
• Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV
• Sildenafil To Prevent Clot
• A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects
• Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment
• Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis
• The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Contr
• CES1 Carriers in the PAPI Study
• Study of Rivaroxaban for CeREbral Venous Thrombosis
• A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis
• CES1 Crossover Trial of Clopidogrel and Ticagrelor
• A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism
• The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
• Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects
• Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
• Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism
• Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
• Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty
• Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC With Major Portal Vein Tumor Thrombosis
• PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
• Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial
• Leiden Trial In Prevention of Post-Operative ThromboEmbolic Events
• PREVENTion of Clot in Orthopaedic Trauma
• Single-dose Pharmacokinetics of BMS-986177 in Participants With Hepatic Impairment Compared to Healthy Participants
• Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus
• A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
• Rivaroxaban or Aspirin for Biological Aortic Prosthesis
• Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
• Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin
• A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects
• Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis
• Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.
• A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)
• A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment
• Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
• Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery
• Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)
• Management of Tunneled Catheter Thrombosis in Hemodialysis Patients: Prospective Study From Qatar
• Tranexamic Acid and Blood Clots in Knee Surgery
• TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV
• Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
• Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)
• Rule Out Transcatheter Aortic Valve Thrombosis With Post Implantation Computed Tomography (RETORIC)
• Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
• A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Pharmacokinetics of BMS-986177 in Healthy Subjects
• Perioperative Bleeding and Aspirin Use in Spine Surgery
• Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
• A Different Approach to Preventing Thrombosis
• Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
• Radial Artery Occlusion After Endovascular Procedure
• Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
• A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer
• Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis
• Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses
• Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.
• Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose
• INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis
• Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients
• Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
• Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients
• Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI Patients
• The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT
• Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study
• Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
• Safety and Tolerability Study of BMS-986177 in Healthy Subjects
• Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial
• Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon
• Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
• Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study
• Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates
• Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.
• Bioequivalence Study of Rivaroxaban
• Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects
• Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis
• Tecarfarin Anti-Coagulation Trial (TACT)
• XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis
• Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children
• Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study
• Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)
• TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
• Evaluation of a New Imagingtechnologie for Thrombosis
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)
• CV004-007 Thrombosis Chamber Study
• Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis
• Enoxaparin Metabolism in Reconstructive Surgery Patients
• The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis
• Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty
• The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
• A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries
• rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome
• Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico
• Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
• Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects
• Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
• Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation
• EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis
• Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study
• Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome
• Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis
• Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra
• Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy
• Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF
• Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis
• Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
• Thrombolytic Therapy Versus Surgery for Obstructive Prosthetic Valve Thrombosis
• Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis
• Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
• Beneficial Effects of Coenzyme Q10 Treatment on the Mitochondrial Dysfunction and Oxidative Stress Associated to Atherothrombosis Developement in Antiphospholipidid Syndrome Patients
• Embolectomy in Acute SYlvian Thrombosis in Refractory or Ineligible Patients to ALteplase
• Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
• Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation
• Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel
• Rivaroxaban Anticoagulation for Superficial Vein Thrombosis
• Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty
• Bioavailability of Apixaban Crushed Tablet
• Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage
• Cancer Venous Thromboembolism (VTE)
• Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity
• Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)
• Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis
• Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis
• Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
• Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer
• Prevention of Recurrence After Thrombolysis in Acute Iliofemoral Venous Thrombosis (PRAIS) Study
• Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion
• Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)
• Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT
• Hormones Inflammation and Thrombosis
• Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin
• Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)
• Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter
• Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
• Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
• Anticoagulation Length in Cancer Associated Thrombosis
• Effect of Low Dose Corticosteroids on Perioperative Markers of Thrombosis and Fibrinolysis in Total Knee Arthroplasty
• Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy
• Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication
• Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients
• AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
• Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)
• A Prospective Pharmacodynamic Study of Rivaroxaban
• Argatroban in Critically Ill Patients With Heparin Resistance
• Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
• Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage
• Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2)
• Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder
• ARIXTRA® Adherence in SVT Patients.
• Oral Rivaroxaban in Children With Venous Thrombosis
• Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA
• A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
• Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.
• A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.
• Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria
• Surgery Versus Fibrinolytic Therapy for Left-sided Prosthetic Heart Valve Thrombosis
• Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver
• Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries
• Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
• Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis
• Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
• Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery
• Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease
• PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients
• Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous Line
• Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
• LV Thrombus After Acute AMI: A Randomized Controlled Trial
• Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation
• Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy
• Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)
• Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
• Switching Study From Warfarin to Rivaroxaban
• Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
• Reversal of the Antithrombotic Action of New Oral Anticoagulants
• Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac Surgery
• Comparison of Different TRansesophageal Echocardiography Guided thrOmbolytic Regimens for prosthetIc vAlve Thrombosis
• Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
• Mechanism Of Stent Thrombosis (MOST) Study
• Erythropoietin and Platelet Activation Markers
• Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.
• A Study to Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants (MK-0000-216 AM1)
• Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin
• A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting
• Comparison of Subcutaneous Heparin and Enoxaparin for Deep Venous Thrombosis (DVT) Prophylaxis in Surgical Intensive Care Patients
• Study Of Lybrel In Relation To Venous Thromboembolism
• Optimal Duration of Anticoagulation in Deep Venous Thrombosis
• Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
• Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis
• Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
• Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis
• Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
• Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
• Pediatric Catheter-related Thrombosis Imaging Study
• Drug Interaction Between Paracetamol and Warfarin
• Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding
• Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure
• Partial Thromboplastin Time During the First 24 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin (UFH)
• Hemorrhage Risk Prescribed Arixtra
• Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users
• ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery
• An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin®
• Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion
• Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
• Rosuvastatin for Preventing Deep Vein Thrombosis
• Platelet Reactivity in Stent Thrombosis Patients
• Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy
• Does Low Dose Oral Vitamin K Improve International Normalized Ratio (INR) Stability?
• Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
• Evicel Study on the Peri-operative Bleeding in Total Knee Prothesis Surgery
• VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
• Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer
• Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)
• Ex Vivo Human Thrombosis Chamber Study
• Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers
• Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis
• Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
• The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
• D-Dimer Guided Oral Anticoagulant Treatment (OAT)
• Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients
• Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures
• Heparin Versus no Heparin on Duration of Peripherally Inserted Central Catheter (PICC) Patency in Neonates
• Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.
• Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients
• A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery
• Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)
• Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection
• Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation
• The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids
• Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis
• Nadroparin for the Initial Treatment of Pulmonary Thromboembolism
• Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
• A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
• A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome
• Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
• Heparin and the Reduction of Thrombosis (HART) Trial
• Anticoagulation Post Laparoscopic Splenectomy
• Platelet Hyperreactivity to Aspirin and Stroke
• Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients
• Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)
• The Use of Prostaglandin E1 in Head and Neck Microsurgery
• Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)
• CASTLE (Clopidogrel And Serum Troponin Level Elevation)
• Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control
• Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis
• Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study
• GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
• Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
• Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer
• Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities
• Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants
• Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)
• Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation
• Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid
• Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT
• Birth Control Pill vs Birth Control Patch Study
• Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy
• Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients
• Atorvastatin for the Treatment of Retinal Vein Occlusion
• Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
• Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients
• Anticoagulant Therapy During Pacemaker Implantation
• Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
• Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
• Efficacy and Safety of Natto Extract
• Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
• Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study
• Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study
• Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
• Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
• Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers
• Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)
• Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
• Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)
• Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
• Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism
• Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
• Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information
• A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery
• Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis
• Ultrasound Findings to Adjust the Duration of Anticoagulation
• Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
• 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
• Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis
• Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)
• Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients
• The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients
• EVENT: Hydrotherapy and Deep Venous Thrombosis
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters
• Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach
• A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"
• Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
• LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin
• Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)
• A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer
• VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis
• Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
• Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT)
• Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs
• Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery
• Alteplase for Blood Flow Restoration in Hemodialysis Catheters
• Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis
• Enoxaparin in Acute Venous Thromboembolic Disease
• Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants
• D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism
• Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study
• A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.
• Treatment of Upper Extremity Deep-Vein Thrombosis
• Odiparcil For The Prevention Of Venous Thromboembolism
• Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery
• A Study Comparing a New Dosing Regimen of Clot-dissolving Drug for Mechanical Heart Valves Which Show Clots
• The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.
• The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section
• Aspirin for the Prevention of Recurrent Venous Thromboembolism
• The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis
• A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study)
• Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin
• Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)
• Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients
• STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery
• The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial
• Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
• Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
• Fixed Dose Heparin Study
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
• The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
• Genetic Determinants of Warfarin Anticoagulation Effect
• Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters
• Oral Vitamin K for Warfarin Associated Coagulopathy
• Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis
• Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)
• Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
• Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins
• Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
• Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
• SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis
• Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)
• Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)
• Study Of Angiomax In Infants Under Six Months With Thrombosis
• Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
• Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
• Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices
• Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis
• The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
• Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
• Postmenopausal Estrogen/Progestin Interventions (PEPI)